Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Emergency contraception Stories

2009-11-02 00:30:00

TOKYO, November 2 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, has entered into a definitive distribution agreement with ASKA Pharmaceuticals Co., Ltd. ("ASKA", TSE First Section Index: 4514) for the commercialisation of the emergency contraceptive pill SOH-075 (NorLevo(R)). NorLevo(R) is an oral emergency contraceptive "morning after...

2009-10-28 14:44:05

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old. "Long-acting contraceptives (the IUD, contraceptive injection or contraceptive implant) are still not widely used", Sergio Haimovich, researcher at the Hospital del Mar in Barcelona and author of the study published in the European...

fab21946183a553913ad48d49dbb96d31
2009-10-20 11:10:00

The condom is now as popular as the pill for UK women, newest figures say. 25% of the 1,093 women surveyed preferred condoms, the same amount that chose the birth control pill. Experts are happy about the figures as condoms fight off sexually transmitted diseases and pregnancy. About half of those who use condoms refer to their desire to not contract STIs as their reason for use. 50% of the 2,557 people questioned in the United Kingdom said TV programs and commercials had informed them...

2009-10-16 06:45:00

MOUNTAIN VIEW, Calif., Oct. 16 /PRNewswire/ -- Based on its annual assessment of companies making innovative contributions in healthcare, Frost & Sullivan recognizes Agile Therapeutics, Inc. (Agile) with the 2009 North American Pharmaceuticals & Biotechnology Healthcare Innovation of the Year Award for its outstanding achievements in drug development. Agile's lead product, AG200-15 with SKINFUSION(TM), offers great potential as a convenient contraceptive option. Not only does this...

2009-10-01 07:30:00

PARIS, October 1 /PRNewswire/ -- HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming...

2009-09-30 01:30:00

TOKYO, September 30 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced the submission of the New Drug Application (NDA) for the emergency contraceptive pill SOH-075 (NorLevo(R)) to Ministry of Health, Labour and Welfare (MHLW) by Sosei Co. Ltd., its wholly owned Japanese subsidiary. NorLevo(R) is an oral emergency contraceptive "morning after pill" which is used to prevent unwanted pregnancy after...

2009-08-28 15:01:00

MORRISTOWN, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17....

2009-07-22 10:55:00

WASHINGTON, July 22 /PRNewswire-USNewswire/ -- Family Research Council Tony Perkins said today that U.S. Rep. Tim Ryan's (D-OH) measure to "reduce the need for abortion" in reality would increase federal funding for Title X family planning and thereby increase the amount of money given by the taxpayers to abortion providers like Planned Parenthood. (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO) "You don't reduce something by subsidizing it," said Perkins. "The Ryan bill...

2009-06-24 15:20:06

The U.S. Food and Drug Administration has approved the first generic version of emergency contraceptive Plan B (levonorgestrel) tablets. The FDA said the generic product will be available by prescription only for women ages 17 and under. Plan B was first approved in 1999 for prescription use for women of all ages. In 2006, Plan B was approved for non-prescription use for women ages 18 and older while still available as a prescription-only product for women ages 17 and under. The FDA's...

2009-04-23 17:02:00

WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) announced late on April 22 that it has expanded over-the-counter access to the morning-after pill, Levonorgestrel or "Plan B," for 17-year-old minors as well as to adults. Deirdre McQuade, Assistant Director for Policy and Communications at the U.S. Conference of Catholic Bishops' Secretariat of Pro-Life Activities, objected to the move in the following statement: "The FDA's court-driven decision to...